| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |